The Daily Telegraph - Money

IN FOCUS BIOTECH GROWTH TRUST

- Immunomedi­cs Geoff Hsu —

We made a 300pc return on this company, which has developed a breast cancer drug, in our last financial year. Gilead Sciences, the pharmaceut­ical company, bought Immunomedi­cs in October last year. Historical­ly takeovers have been a driver of biotech returns and we have been happy to see that merger activity didn’t diminish during the pandemic.

Newspapers in English

Newspapers from United Kingdom